Results 111 to 120 of about 1,554 (191)

Isatin-pyridine oxime hybrids as potential reactivators of A-242-inhibited acetylcholinesterase. [PDF]

Arch Toxicol
Pinto AMV, Bhattacharyya D, da Silva MCJ, Kitagawa DAS, Dos Santos MC, Cavalcante SFA, Islam ST, LaPlante SR, Forgione P, Diz JSF, França TCC.   +10 more
europepmc   +1 more source

Click-chemistry-derived oxime library reveals efficient reactivators of nerve agent-inhibited butyrylcholinesterase suitable for pseudo-catalytic bioscavenging. [PDF]

Arch Toxicol
Čadež T, Maček Hrvat N, Šinko G, Kalisiak J, Radić Z, Fokin VV, Sharpless KB, Taylor P, Kovarik Z.   +8 more
europepmc   +1 more source

Reactivate

Canadian Journal of Rural Medicine
openaire   +2 more sources

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases. [PDF]

Breast
Wessels PH, Cornelissen S, Monkhorst K, Sonke GS, Broeks A, Linders D, van den Broek D, Boelens MC, Brandsma D.   +8 more
europepmc   +1 more source

Rezatapopt (PC14586): A First-in-Class Small Molecule p53 Y220C Mutant Protein Stabilizer in Clinical Trials. [PDF]

J Med Chem
Ma Z, Shen Q, Zhou J.
europepmc   +1 more source

The roles of mutant p53 in reprogramming and inflammation in breast cancers. [PDF]

Cell Death Differ
Kummar S, Fellous M, Levine AJ.
europepmc   +1 more source

UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma. [PDF]

Clin Cancer Res
Zhou F, Sun Y, Chen X, Wu D, Tao Z, Wu L, Chen G, Liu X, Yu T.   +8 more
europepmc   +1 more source

Eprenetapopt in combination with Palbociclib exerts synthetic lethality in mantle cell lymphoma. [PDF]

Transl Oncol
Dong L, Zhang Y, Chen F, Jiang W, Qian S, Song W, Yang S, Wu X, Li Z, Zhang M.   +9 more
europepmc   +1 more source

TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Rabab KE, Buchanan PJ, Colley G, White A, Murphy A, McCormack C, Eustace AJ.   +6 more
europepmc   +1 more source

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53. [PDF]

Front Pharmacol
Taritsa IC, Fossel ET.
europepmc   +1 more source